Lysine221 is the general base residue of the isochorismate synthase from Pseudomonas aeruginosa (PchA) in a reaction that is diffusion limited by Meneely, Kathleen M. et al.
Lysine221 is the general base residue of the isochorismate
synthase from Pseudomonas aeruginosa (PchA) in a reaction
that is diffusion limited
Kathleen M. Meneely1, Qianyi Luo1, Prajnaparamita Dhar2, and Audrey L. Lamb1,*
1Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045
2Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045
Abstract
The isochorismate synthase from Pseudomonas aeruginosa (PchA) catalyzes the conversion of
chorismate to isochorismate, which is subsequently converted by a second enzyme (PchB) to
salicylate for incorporation into the salicylate-capped siderophore pyochelin. PchA is a member of
the MST family of enzymes, which includes the structurally homologous isochorismate synthases
from E. coli (EntC and MenF) and salicylate synthases from Yersinia enterocolitica (Irp9) and
Mycobacterium tuberculosis (MbtI). The latter enzymes generate isochorismate as an intermediate
before generating salicylate and pyruvate. General acid – general base catalysis has been proposed
for isochorismate synthesis in all five enzymes, but the residues required for the isomerization are
a matter of debate, with both lysine221 and glutamate313 proposed as the general base (PchA
numbering). This work includes a classical characterization of PchA with steady state kinetic
analysis, solvent kinetic isotope effect analysis and by measuring the effect of viscosogens on
catalysis. The results suggest that isochorismate production from chorismate by the MST enzymes
is the result of general acid – general base catalysis with a lysine as the base and a glutamic acid as
the acid, in reverse protonation states. Chemistry is determined to not be rate limiting, favoring the
hypothesis of a conformational or binding step as the slow step.
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Introduction
The menaquinone, siderophore and tryptophan (MST) family of enzymes are structurally
homologous, Mg2+-dependent, chorismate-utilizing enzymes that 1) isomerize the ring to
form isochorismate for menaquinone and siderophore biosynthesis (Figure 1a), 2) replace
the C4-OH with an amine to generate aminodeoxychorismate for folate biosynthesis, or 3)
remove the C4-OH and add a C2-amine to produce aminodeoxyisochorismate for tryptophan
biosynthesis (1-3). The focus of this study is an enzyme that catalyzes the first reaction,
PchA, the isochorismate synthase from Pseudomonas aeruginosa. The isochorismate that is
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produced by PchA is subsequently converted to salicylate and pyruvate by the
isochorismate-pyruvate lyase PchB (Figure 1b), and the salicylate is incorporated into the
salicylate-capped siderophore pyochelin (4, 5). Other isochorismate synthases have been
characterized, including EntC (6, 7), which is involved in the formation of the
dihydroxybenzoate-capped siderophore enterobactin, and MenF(2), which is in the pathway
for formation of the electron-carrier menaquinone (Vitamin K), both from Escherichia coli.
Irp9 and MbtI are salicylate synthases (Figure 1c) involved in salicylate-capped siderophore
biosynthesis, yersiniabactin of Yersinia enterocolitica (8-10) and mycobactin of
Mycobacterium tuberculosis (3, 11), respectively. These latter two enzymes generate an
isochorismate intermediate using a general acid – general base mechanism hypothesized to
be common to all five, but also have isochorismate-pyruvate lyase activity to form
salicylate (3, 9, 11). The structures of MenF (2) , EntC (6, 7), Irp9 (8) and MbtI (3, 11, 12) have
been determined and the active sites are shown to be architecturally similar and built from
highly conserved amino acids. The structure of PchA remains elusive but is hypothesized to
be homologous based on sequence conservation, especially in the active site amino
acids (13).
The formation of isochorismate by both the isochorismate and salicylate synthases has been
hypothesized to be catalyzed by a general acid – general base mechanism shown in Figure
1a (2, 3, 8, 14, 15). The proposal (2, 3) was that a lysine residue (221 in PchA) served as the
general base, accepting a proton from water, thereby activating the water molecule for
nucleophilic attack at the 2 position of the substrate ring. The hydroxyl at the 4 position
accepts a proton from a glutamic acid general acid (269 in PchA) thereby making it a good
leaving group. The lysine general base residue was chosen based on the crystal structures of
MST enzymes which showed this residue to be in proximity to a water molecule in the
appropriate position for activation and catalysis (2, 3, 9, 15). This family-wide hypothesis (1)
has found support from mutational analyses in MenF (2), Irp9 (8) and MbtI (3) that showed a
loss of isochorismate synthase activity in variants in which the general base lysine was
replaced with alanine or the general acid glutamic acid was replaced with alanine or
glutamine. Recent work by Ziebart and Toney (15) on EntC and MbtI puts this hypothesis in
question, as they found that lysine to glutamine variants retained some activity. A second
general acid – general base proposal based on a computational model of MbtI (14) suggests
that the general base is instead a glutamic acid (313 in PchA): the lysine was calculated to
have a pKa of 10.9, and thus was reasoned to be protonated in the active site and unsuitable
as a general base, whereas the glutamic acid was calculated to have a pKa value of 6.55 and
thus be more likely to accept a proton at physiological pH. It should be noted that these
calculations were conducted using a model based on a structure lacking the catalytically
required magnesium ion. Other structures from the MST family members (Irp9, MenF)
show that the glutamic acid proposed to serve as a base (equivalent to E313 in PchA) is
involved in metal ion chelation. To directly test the hypotheses of general acid – general
base catalysis in this family, we document here the first solvent isotope effects experiments
for any member of this family, specifically PchA. These data, in conjunction with
viscosogen data, are most consistent with the original model of a lysine general base and a
glutamic acid general acid, with these two residues in reverse protonation states.
Materials and Methods
Preparation of overexpression plasmids
The pchA gene was amplified from P. aeruginosa PA01 genomic DNA by polymerase chain
reaction by use of Master Mix (Eppendorf). The forward primer (Table 1) includes an NdeI
site (underlined), whereas the reverse primer contains a HindIII site (underlined). The
amplified 1431 base pair fragment was digested with NdeI and HindIII and ligated into the
pET28b plasmid (Novagen) digested with the same enzymes. The resulting plasmid contains
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the pchA gene with an N-terminal histidine tag. The PchA variants were produced using
QuikChange (Agilent) with wildtype pchA plasmid as the template with primers as shown in
Table 1. Each variant plasmid only contained the desired mutation.
Protein overexpression and purification
BL21 (DE3) pLysS E. coli containing the PchA expression plasmid were grown in terrific
broth medium supplemented with 0.4% (v/v) glycerol and containing 50 μg/mL kanamycin
at 37 °C with shaking (225 rpm) until an OD600 of ~1.0 was reached. The culture was
induced with 0.2 mM isopropyl β-D-thiogalactopyranoside and temperature was reduced to
25 °C. The cells were harvested by centrifugation (6,000xg, 10 min, 4 °C) after 20-22 h. The
cell pellet was resuspended in 15 mL of 25 mM Tris-HCl pH 8, 500 mM KCl, 5 mM
imidazole, 20% glycerol (buffer A) per liter of culture. Cells were disrupted by use of a
French pressure cell (35,000 psi), and cellular debris was removed by centrifugation
(12,000xg, 45 min, 4 °C). The supernatant was applied to a chelating Sepharose fast-flow
column (Amersham Biosciences) charged with nickel chloride and pre-equilibrated in buffer
A. PchA protein eluted at 300 mM imidazole in a step gradient of 30 mM, 45 mM, 150 mM
and 300 mM imidazole in buffer A. The pooled fractions were applied to a Superdex 200
size-exclusion column (Amersham Biosciences) equilibrated with 50 mM Tris-HCl pH 8, 50
mM KCl, 50 mM sodium citrate, 10% glycerol. The fractions containing PchA were pooled
and concentrated by use of an Amicon stirred cell with a YM-30 membrane to 5-25 mg/mL
as determined by the Bradford assay and stored at −80 °C. PchA variants were
overexpressed and purified in the same manner as wildtype PchA. PchB for use in the
coupled assay with PchA was purified as previously described (16).
Preparation of isochorismate and chorismate
Isochorismate was isolated from Klebsiella pneumoniae 62-1 harboring the entC plasmid
pKS3-02 (17) with only minor changes, as described previously (18). Chorismate was isolated
from K. pneumoniae 62-1 as previously described (19) with few modifications. Briefly,
growth medium (1 L) was inoculated with 10 ml of K. pneumoniae 62-1 overnight culture
(grown at 30 °C with shaking at 250 rpm) and incubated at 30 °C with shaking (250 rpm)
until OD625 of ~2.0. Growth medium contained per liter: 0.2 g MgSO4·7H2O, 2 g citric acid
monohydrate, 10 g anhydrous K2HPO4, 3.5 g NaNH4PO4·4H2O, 2 g yeast extract, 2 g
casamino acids, and 41 mg DL-tryptophan. Glucose (10 ml of 16% (w/v)) was added after
autoclaving. The cells were harvested by centrifugation (6,000x g, 10 min, 4 °C) and
resuspended in 1 L accumulation medium. Accumulation medium contained per liter: 12.8 g
Na2HPO4, 1.36 g KH2PO4, 18 g glucose, 2.7 g NH4Cl, 2 ml of a 50 mM solution MgCl2,
20.5 mg DL-tryptophan, 1 ml of a 100 mM solution L-phenylalanine, and 1 ml of a 10 mM
solution (NH4)2Fe(SO4)2. Accumulation medium was prepared fresh and not autoclaved.
After incubated at 30 °C with shaking (250 rpm) for 16 to 18 h, the culture was centrifuged
(6,000x g, 20 min, 4 °C), the supernatant collected, and the pH adjusted to 8.5 by slowly
adding 10 M NaOH or NaOH pellets on ice to prevent the sample from heating. The
accumulation culture supernatant (5 L) was mixed with approximately 150 ml of Dower-Cl
1×8 resin (Sigma) and stirred for 30 min at 4 °C. The resin with chorismate bound was
washed with 300 ml of H2O three times and packed into an XK 50/20 column (GE
Healthcare). The chorismate was eluted with three column volumes of 2 M NH4Cl pH 8.5 at
3 ml/min after equilibration with 1 column volume of H2O. Fractions (10 ml) were collected
and any fraction with the OD275 over 0.3 (1 to 100 dilution) was pooled and the pH adjusted
to 1.5 with 10 M HCl. The chorismate was extracted with ether and crystallized as
previously described (19). After a recrystallization process, the final yield of chorismate was
200 mg per liter of culture and >90% pure as evaluated by HPLC and 1H-NMR analyses.
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Isochorismate synthase activity assays
The standard assay buffer contained 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10% glycerol.
Enzyme was added and incubated with a 20-fold excess of PchB and the reaction was
initiated by the addition of chorismate (0-300 μM). Initial velocities were determined at 25
°C by measuring the accumulation of salicylate by fluorescence with an excitation
wavelength of 310 nm and an emission wavelength of 430 nm using a Cary Eclipse
fluorescence spectrophotometer (Varian) and an electrothermal single cell holder for
temperature control (0.1 °C). For the wildtype PchA assays, the enzyme concentration was
0.1 μM, and for the PchA variants, the enzyme concentration was 10 μM. For the PchA
solvent isotope effect assays, the reaction buffer contained 50 mM formate, 50 mM MES,
100 mM Tris-HCl, 10 mM MgCl2, 10% glycerol at pH 6-9 with an enzyme concentration of
0.1 μM.
Isochorismate-pyruvate lyase activity assays
Isochorismate-pyruvate lyase assays were performed using a TgK Scientific Stopped-Flow
device operated at 25 °C, with a xenon lamp with the monochromator set at 310 nm, and a
360 nm cutoff filter. Equal volumes of enzyme and substrate were injected into a 22 μl cell
and initial velocity of salicylate production was collected for 30 seconds during which the
reaction was linear. Pre-injection enzyme and substrate concentrations were twice the final
enzyme/substrate concentration in the cell (post mixing). Unless otherwise specified, all
concentrations reported are final post-mixing concentrations. Both the isochorismate
substrate and enzyme were prepared in the same standard reaction buffer to prevent buffer
dilution effects post mix. Isochorismate was prepared to a desired post-mix final
concentration of 0 – 400 μM and enzyme concentrations used for the assays with wildtype
PchA and PchA variants were 10 μM.
Salicylate synthase activity assays
Salicylate production with wildtype PchA and PchA variants was measured using 10 μM
enzyme and the reaction was initiated with 1 mM chorismate. The different enzymes or
variants were added individually to the standard reaction buffer. Initial velocities were
determined at 25 °C by measuring the accumulation of salicylate by fluorescence with an
excitation wavelength of 310 nm and an emission wavelength of 430 nm using a Cary
Eclipse fluorescence spectrometer (Varian) with temperature controller.
Chorismate mutase activity assays
Initial velocities were measured in 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10% glycerol or
with 50 mM Tris-HCl pH 7.5, 1 mM EDTA, 10% glycerol at 25 °C with 25 μM enzyme
according to the method optimized by Gaille et. al (4). The reaction was initiated by the
addition of chorismate, varied in concentration from 0 to 10 mM. At the various time points,
40 μl of reaction mixture was removed and the reaction was terminated with 20 μl 1 M HCl.
The reaction product, prephenate, was converted to phenylpyruvate upon incubation at 37
°C for 20 min. The phenylpyruvate concentration was determined at 320 nm under basic
conditions by the addition of 140 μl of 2.5 M NaOH (ε320 = 17,500 M−1cm−1) using a Cary
50 Bio spectrophotometer (Varian) with an electrothermal single cell holder for temperature
control (± 0.1 °C).
Viscosity measurements
Solvent viscosities in 50 mM Tris pH 7.5, 10 mM MgCl2 were determined using a digital
cone-and-plate viscometer (DVII+ Pro, CP-40 0.8° cone, Brookfield Engineering,
Middleboro, MA). The temperature was controlled at 25 °C. A sample of 0.6 ml was used
for all measurements at a final shear rate of 60 rpm, while an initial sweep of shear rates was
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done to ensure that the measurements are in the linear regime. The torque was always at
greater than 10% to ensure accuracy of the data. Viscosities are calculated by in-built
software using well-established relations between the applied shear stress, shear rate and
viscosity. The reported viscosities are averages for 4-5 measurements for each solution: ηavg
= 1.32, 1.88, and 2.75 cP for 10, 20, and 30% (v/v) glycerol solutions, respectively; ηavg =
1.76, 2.44 and 4.27 cP for 20, 30, and 40% (w/v) sucrose solutions; ηavg = 1.40, 1.84, and
2.59 cP for 10, 20, and 30% (w/v) sorbitol solutions; ηavg = 1.33 and 1.95 cP for 10 and 20%
(v/v) poly(ethylene glycol) 200 solutions; ηavg = 1.52, 1.96, and 5.33 cP for 1.7, 3.3, and
6.7% (w/v) poly(ethylene glycol) 8000 solutions. Kinetic parameters in different viscosogen
solutions were determined with the isochorismate synthase activity assay using a TgK
SF-61DX2 stopped-flow apparatus with a final enzyme concentration of 0.1 μM for
wildtype PchA and 25 μM for PchB at 25 °C. Final chorismate concentrations ranged from 0
– 10 μM. The microviscogen data used to determine the slope of the line include the
sucrose, PEG200, and sorbitol values. The glycerol data were omitted from the curve fit
because they are classically known to be non-linear (20), as can be seen in these data also.
The PEG8000 data were used to determine the slope of the line for the macroviscogens.
Data analysis
Kinetic parameters were determined using the Michaelis-Menten equation with the
nonlinear regression function of KaleidaGraph (Synergy Software). Henderson and Dixon
plots were used at sub-saturating concentrations of substrate (21). pH plots were fit to the
equation
(1)
where y is the observed kinetic parameter (kcat or kcat/Km), c is pH independent value of y,
and H is the proton concentration. Buffers in D2O were corrected for isotope effects on the




and where n is the fraction of D2O (22).
Results
PchA purification and isochorismate synthase wildtype kinetic parameters
PchA was previously shown to be an isochorismate synthase enzyme that converts
chorismate into isochorismate and was reported to be expressed only in conjunction with
expression of PchB (5, 23). In our hands, PchA containing an N-terminal His tag allowed for
~90 mg of PchA to be purified per liter of culture without coexpression of PchB, resulting in
>98% purity after two chromatographic steps. The isochorismate synthase activity of PchA
requires Mg2+ (24) and exhibits Michaelis-Menten kinetics. Isochorismate synthase kinetic
parameters were determined for wildtype and variant PchA using a coupled assay in which
isochorismate produced by PchA is converted to the fluorescent salicylate by the
isochorismate-pyruvate lyase, PchB (5). PchB is used in 20-fold molar excess such that any
isochorismate produced is immediately converted into salicylate. The previous
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characterization of PchA upon co-purification with PchB gave comparable kinetic values,
after consideration for differences in temperature and assay buffer (5).
Purification of variants of PchA
The variants of PchA were purified in the same manner as the wild type enzyme. The yield
per liter of culture for the variant enzyme was 90 – 270 mg, with comparable purity.
Isochorismate-pyruvate lyase kinetic parameters
Isochorismate-pyruvate lyase activity (Figure 1b) had not been previously documented for
PchA. Using an assay measuring the production of the fluorescent salicylate product
(excitation 310 nm and emission >360 nm) from an isochorismate substrate, kinetic
parameters could be determined: kcat = 0.00070 ± 0.00001 s−1, Km = 42 ± 2 μM; kcat/Km =
17 ± 1 M−1s−1.
Chorismate mutase activity
Chorismate mutase activity (Figure 1d) has previously been detected for the salicylate
synthase enzyme MbtI but only in the absence of magnesium (3). A more recent study did
not detect any chorismate mutase activity for MbtI or EntC (15). We did not detect
chorismate mutase activity for PchA or any of the variants in the presence or absence of
magnesium.
E269A-PchA (loss of general acid) and K221A- or E313(A/Q)-PchA (loss of general base)
variants
Generation of a variant of the proposed general acid in PchA, E269A, yielded enzyme with
no detectable isochorismate synthase activity (Table 2) as was also demonstrated with the
isochorismate synthase homolog MenF (2) and the salicylate synthase homologs Irp9 (8) and
MbtI (3). Mutation of the two proposed general base residues of PchA to alanine, K221A and
E313A, yielded variants with detectable isochorismate synthase activity that was 4 orders of
magnitude less than the wildtype enzyme. This is in contrast to the similar lysine to alanine
variants of MenF (2) or MbtI (3), for which activity was not detected. A mutation of lysine to
glutamine at the same position in EntC and MbtI showed 5-8% of the activity of
wildtype (15), higher than seen for the alanine variant. The comparable variant in PchA,
E313Q, showed a decrease in activity of three orders of magnitude. The mutational analyses
are not definitive for either model (a lysine or glutamic acid general base). Indeed, they
cannot be, since a loss of activity upon generation of a variant may be the result of a small or
large perturbation in structural integrity, due to changes in binding affinity, or due to the loss
or gain in the proposed catalytic property.
PchA pH rate profile and solvent kinetic isotope effects
Isochorismate synthase kinetic parameters were determined for wildtype PchA at pH values
6 to 9 in H2O. The coupled assay described above was again used. PchB has been shown
previously to have constant activity throughout the pH range tested (25). The secondary
structure of PchA was monitored at the pH extremes and found to be intact by circular
dichroism, but the protein was not stable at pH values below 6 or above 9 (data not shown).
A plot of the log kcat/Km versus pH for PchA shows a classic bell curve with optimal
activity at pH 7.5. The curve had apparent slopes of +1 and −1 on the respective acidic and
basic sides of the profile. Fitting of the data produced pKa values of 5.43 and 9.92 (Figure 2a
circles and Table 3). The plot of log kcat versus pH was also defined by a bell-shaved curves
with slopes of +1 and −1, which upon fitting gave pKa values of 5.61 and 9.74 (Figure 2b
circles and Table 3). Similarly, plots of log kcat/Km or log kcat versus pD (Figure 2a and 2b
squares) showed a shift in the pKa values (ΔpK) of 0.3-0.6 as expected (Table 3) (26). We
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note that the pKa values are outside the pH range tested. Nevertheless, the values are
consistent in all of the experiments, and the small differences in the values do not change the
outcome of the calculations found in the discussion section.
The determined pKa values are consistent with glutamic acid and lysine residues in a general
acid – general base mechanism with reverse protonation states. In other words, K221 is the
general base yet the pKa is observed for this residue at the basic side of the pH profile, and
E269 is the general acid with the pKa for this residue observed at the acidic side of the
profile. This is not uncommon in enzymes where the protonation state is different in the
forward and reverse reactions (27-30). The isochorismate synthases, in particular EntC (31, 32),
MenF (31), and PchA (5), have been documented to be efficient at both the forward and
reverse reactions.
In 95% D2O over the same pH range, a negligible D(kcat/Km) solvent kinetic isotope effect
(1.09 ± 0.06) was determined (Figure 2a diamonds and Table 3). The values of kcat/Km for
PchA in H2O, 50% D2O and D2O were within 10% of each other, suggesting that the proton
transfer steps are not rate-limiting. A small, normal D(kcat) solvent kinetic isotope effect of
1.25 ± 0.3 was determined (Figure 2b diamonds and Table 3). This value is more than likely
inflated relative to the kcat/Km value as a result of the viscosity difference between H2O and
D2O(33) and the large viscosity effect for this enzyme described below. A general acid –
general base mechanism with a proton transfer occurring in the rate-determining step would
suggest that significant solvent isotope effects would be observed with kinetic parameters
reduced by up to 4-5 fold with deuterium oxide as solvent. Thus, solvent isotope effects
would be expected if proton transfer from the nucleophile water at C2 to K221 or E313 and/
or proton transfer to the departing hydroxyl at C4 from E269 is rate-limiting in the reaction.
If these proton transfers occur in relatively fast steps, then the solvent isotope effects would
be small, which seems more likely from these data.
Viscosogen data
Since the chemistry step (general acid – general base) is shown above to not be rate-limiting,
a viscosogen study was initiated to determine if the enzyme is limited by diffusive effects –
if substrate binding or product release are rate-limiting (Figure 3). We should note that these
data are also collected using a coupled assay with PchB in 200-fold excess (in contrast to
20-fold excess in the previous experiments) to convert the product isochorismate of the
PchA reaction into the fluorescently detectable salicylate. The dependence of kcat with
respect to viscosogens indicates that the reaction is diffusion controlled, or that the substrate
on rate or product off rate has been slowed. Previous documentation suggests that data of
this nature is only reliable for slopes between the ranges of 0.2 and 0.8, and that slopes close
to 0 or 1 are error prone and insufficient for the determination rate constants (34).
Nevertheless, the data qualitatively indicate that in the presence of microviscogens (sucrose,
glycerol, sorbitol, PEG200), the reaction is diffusion controlled (a slope of ~1) (35, 36). In the
presence of macroviscogens (PEG8000), the slope is ~0, suggesting that the effects on
substrate binding or product release are not due to major protein conformational changes.
Discussion
Four possible mechanisms for this class of enzymes were originally proposed based on data
for EntC, the isochorismate synthase from E. coli (37). In all four, it was assumed that the
magnesium ion chelates the 4-hydroxyl-group of substrate to make it a good leaving group
or is part of a magnesium bound transition state (37). However, all of the structures of the
MST enzymes in which ligands are bound (substrate or product) have shown that the
magnesium is chelated by the carboxylate attached at the 1-position of the ring (7, 8, 38). A
second proposal suggested general acid-general base chemistry with nucleophilic attack at
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C2 and elimination of the C4-OH (1), assisted by the development of a partial positive
charge to increase the electrophilicity at C2 due to chelation of the C1-carboxylic acid to the
magnesium ion (Figure 1a) (3). A lysine general base residue and a glutamic acid general
acid were chosen based on the crystal structures of MST enzymes based on proximity and
positioning for activation and catalysis (Figure 4, residues in yellow) (2, 3, 9, 15). A third
mechanistic hypothesis has a basis in the computational determination of pKa values of
residues in the active site of MbtI, and proposes two glutamic acid residues serving in the
roles of general base and general acid (Figure 4, orange glutamic acid is general base) (14).
Mutagenic analyses previously conducted (2, 3, 8, 9, 15) and herein show that changes at the
hypothesized sites do reduce or abrogate catalytic activity. However, a mutationally induced
loss of activity suggests only some catalytic role for the residue of interest, among which
may be acid/base function or a critical hydrogen bonding, electrostatic, or steric interaction.
To test the hypothesis of general acid – general base chemistry more explicitly, pH-rate
profiles and solvent isotope effect experiments of the isochorismate synthase PchA were
performed (Figure 2). The pH rate profiles indicate that one catalytic residue must be
deprotonated for maximal activity and one must be protonated. Therefore, we propose that
EH is the catalytically viable form as opposed the EH2 (in which both are protonated) or E
(in which neither are) (Figure 5). The pKa values determined are more consistent with a
model containing one glutamic acid (pKa ~5.5 to 6) and one lysine (pKa ~9.75 to 10.5), as
opposed to a model with two glutamic acid residues.
In the equation for fitting of the pH-rate profiles (equation 1), c represents the pH
independent value of kcat/Km (or kcat), or more precisely, the limiting value when all of the
enzyme is in the active protonation state (EH). The denominator provides the fraction of the
free enzyme in this protonation state. When considering the kcat/Km data, we calculate a
pKa1 = 5.43 (or Ka1 = 3.7×10−6) and a pKa2 = 9.92 (or Ka2 = 1.2×10−10), with a maximal
kcat/Km value (c) of 19,200 M−1s−1. The fraction of the EH active form can be calculated,
using the denominator of equation 1:
(4)
Since this is the denominator, and used to divide our maximal kcat/Km, this number indicates
that 97% of the enzyme (1/1.03 = 0.97) is in the EH form at pH 8. It follows that 3% is in
the E or EH2 forms.
There are two possibilities for EH: a Glu−/LysH+ zwitterion or a GluH/Lys neutral form
(Figure 5). The most common state at pH 8 would be the Glu−/LysH+ zwitterion form,
consistent with a Glu− general base residue that must be deprotonated and LysH+ general
acid residue that must be protonated for activity. The equilibrium constant for the
conversion of the zwitterionic form to the neutral form can be calculated as
(5)
indicating that nearly all is indeed in the zwitterionic form. However, we hypothesize that
the GluH/Lys neutral form is the active tautomer, in which the Lys general base must be
deprotonated and the GluH general acid must be protonated for activity. The theoretical kcat/
Km when all enzyme is in the neutral form can be calculated using the equation
(6)
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where x is the kcat/Km of the neutral tautomer (GluH/Lys) in the active protonation state
(EH). Now, solving for x,
(7)
(8)
This value is ~100-fold less than the diffusion limit of ~109-1010 M−1s−1, which is the
largest possible value for this rate constant. These calculations suggest that our mechanism
of acid-base catalysis is possible (a value of x greater than 1010 M−1s−1 would indicate the
model unlikely), in which the GluH/Lys is the active conformer, the GluH serves as the
general acid and the Lys serves as the general base. These calculations are also consistent
with the absent or small solvent isotope effect. The viscosogen data suggest that the reaction
is diffusion controlled (microviscogens) and that the effects on substrate binding or product
release are not due to major protein conformation changes (macroviscogens). Since the
catalyzed reaction is fully reversible, the effect of viscosogens may be related to competition
in the active site for chorismate (considered the substrate for this biosynthetic pathway) and
isochorismate (product). In light of the pH rate profiles, the diffusion control is also likely a
consequence of requiring an encounter of the substrate with the relatively unpopulated EH
neutral catalytic form of the enzyme.
Conclusions
The isochorismate synthase PchA uses a (deprotonated) lysine general base residue to
activate a water molecular for nucleophilic attack of the chorismate ring at the C-2 position.
This is concomitant with a (protonated) glutamic acid serving as a general acid to make the
C-4 hydroxyl a good leaving group (Figure 5b). The requirement for the catalytic residues in
reverse protonation states is supported by pH rate profiles, solvent kinetic isotope effect
analyses, and viscosogen data. These results can be extrapolated to the other MST family
members, providing a family-wide mechanism for the isomerization of the chorismate ring.
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MenF isochorismate synthase from E. coli
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biosynthesis
PchA isochorismate synthase from Pseudomonas aeruginosa
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• The general acid-general base catalysts are identified in MST enzymes.
• Catalysis is diffusion controlled in the isochorismate synthase reaction.
• Evidence for reverse protonation states of the catalytic acid/base is presented.
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Reactions catalyzed by isochorismate and salicylate synthases of siderophore and
menaquinone biosynthesis.
Meneely et al. Page 13













Figure 2. PchA pH and pD rate profiles for kcat/Km (A) and kcat (B)
PchA isochorismate synthase activity vs. pH in H2O (●), D2O (◆), and 50% D2O (■) with
curve fit lines for H2O (solid line) and D2O (dashed lines). The solvent kinetic isotope effect
is approximately unity suggesting that the proton transfer steps are not rate limiting.
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The effect of viscosogens on the turnover number: glycerol (○), sucrose (□), PEG200 (◇),
sorbitol (△), and PEG8000 (●). The solid lines represent the curve fit for the low-molecular
weight viscosogens (open symbols) and the high-molecular weight viscosogen (closed
symbols). The dashed line represents the line with a slope of 1 for a completely diffusion
controlled rate of reaction. There is a significant effect on the rate of catalysis in the
presence of microviscogens in support of the hypothesis that substrate binding or product
release is rate limiting. There is no significant effect on the rate of catalysis with
macroviscogens, suggesting that a large protein conformational change is not rate limiting.
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Figure 4. Irp9 active site with proposed general acid-general base residues highlighted
The overall structure of Irp9 (PDB: 2FN1) is shown as the transparent cartoon. The active
site residues are shown in grey with the exception of the residues of interest herein.
Salicylate and pyruvate are blue. The magnesium ions (bright green) and coordinating
waters (red) are shown as spheres. Amino acids are labeled with Irp9(PchA) numbering. The
residues highlighted in yellow are the proposed general acid, E240(269), and general base,
K193(221). Note the water molecule (red sphere) poised between the lysine and salicylate,
that has been suggested to be the water activated for catalysis. The general acid proposed
from computational experiments that also chelates the metal ion is highlighted in orange,
E284(313). This figure was generated with PyMOL (39).
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Proposed Mechanism of Isochorismate Synthase (PchA).
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Table 1
Primers used to generate wildtype and variant PchA enzymes.
Amino acid Putative Function Primer
PchA Wildtype
forward 5′-AAT TAT ATA CAT ATG AGC CGG CTG GCG CCC CTG-3′
reverse 5′- CCC AAG CTT TCA GGC GAC GCC GCG CTG-3′
PchA Variants
K221A General base 5′- GGG ACG CTT CGG CGC GGT CGT GCT GGC-3′
E269A General acid 5′- GCG CCT CCC CGG CAC GCC TGG TCC G-3′
E313A Chelates Mg2+, general base 5′-CAA GGA CAG GCA CGC ACA CCA GTT GGT GG-3′
E313Q Chelates Mg2+, general base 5′-CCA AGG ACA GGC ACC AAC ACC AGT TGG TG-3′
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Table 2
Isochorismate Synthase activity for PchA variants of putative general acid – general base amino acids. The
assay is a coupled one with 20-fold excess isochorismate-pyruvate lyase (PchB) to convert isochorismate to
salicylate, which can be monitored by fluorescence with excitation at 310 nm and emission at 430 nm.
k cat (×10−3 s−1) K m (μM) k cat/K m (M−1s−1)
PchA
    WT 50.4 ± 0.2 0.9 ± 0.1 57,000 ± 7,000
    K221A 0.0455 ± 0.0001 21 ± 3 2.2 ± 0.3
    E269A
ND
a ND -
    E313A 0.108 ± 0.001 17 ± 1 6.4 ± 0.4
    E313Q 0.75 ± 0.04 12 ± 3 60 ± 10
a
not detected
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Table 3
pK values and kinetic constants determined from curve fitting of pH and pD rate profiles using equations
outlined in the methods.
solvent k cat/K m pK value (k cat/K m) k cat pK value (k cat) solvent kinetic isotope effect
H2O 19,200 ± 200 M−1s−1 pK a1 = 5.43 ± 0.04 0.076 ± 0.002 s−1 pK a1 = 5.61 ± 0.03 D(k cat/K m) = 1.09 ± 0.06
pK a2 = 9.92 ± 0.02 pK a2 = 9.74 ± 0.04
D2O 17,600 ± 900 M−1s−1 pK a1 = 5.77 ± 0.04 0.0606 ± 0.0003 s−1 pK a1 = 6.20 ± 0.03 D(k cat) = 1.25 ± 0.03
pK a2 = 10.41 ± 0.05 pK a2 = 10.01 ± 0.01
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